DE69814851T2 - Verwendung von levobupivacaine in gesichtschirugie - Google Patents

Verwendung von levobupivacaine in gesichtschirugie Download PDF

Info

Publication number
DE69814851T2
DE69814851T2 DE69814851T DE69814851T DE69814851T2 DE 69814851 T2 DE69814851 T2 DE 69814851T2 DE 69814851 T DE69814851 T DE 69814851T DE 69814851 T DE69814851 T DE 69814851T DE 69814851 T2 DE69814851 T2 DE 69814851T2
Authority
DE
Germany
Prior art keywords
levobupivacaine
bupivacaine
surgery
drug
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69814851T
Other languages
German (de)
English (en)
Other versions
DE69814851D1 (de
Inventor
Albert Brian GENNERY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of DE69814851D1 publication Critical patent/DE69814851D1/de
Application granted granted Critical
Publication of DE69814851T2 publication Critical patent/DE69814851T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69814851T 1997-03-03 1998-03-03 Verwendung von levobupivacaine in gesichtschirugie Expired - Lifetime DE69814851T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9704352 1997-03-03
GBGB9704352.5A GB9704352D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
PCT/GB1998/000657 WO1998038996A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in facial surgery

Publications (2)

Publication Number Publication Date
DE69814851D1 DE69814851D1 (de) 2003-06-26
DE69814851T2 true DE69814851T2 (de) 2004-01-22

Family

ID=10808603

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69814851T Expired - Lifetime DE69814851T2 (de) 1997-03-03 1998-03-03 Verwendung von levobupivacaine in gesichtschirugie

Country Status (20)

Country Link
US (1) US5919804A (cg-RX-API-DMAC7.html)
EP (1) EP0981347B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513812A (cg-RX-API-DMAC7.html)
KR (1) KR100516676B1 (cg-RX-API-DMAC7.html)
CN (1) CN1089585C (cg-RX-API-DMAC7.html)
AT (1) ATE240730T1 (cg-RX-API-DMAC7.html)
AU (1) AU730390B2 (cg-RX-API-DMAC7.html)
BR (1) BR9808303A (cg-RX-API-DMAC7.html)
CA (1) CA2279497C (cg-RX-API-DMAC7.html)
DE (1) DE69814851T2 (cg-RX-API-DMAC7.html)
DK (1) DK0981347T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199423T3 (cg-RX-API-DMAC7.html)
GB (1) GB9704352D0 (cg-RX-API-DMAC7.html)
HU (1) HU225151B1 (cg-RX-API-DMAC7.html)
IL (1) IL131084A0 (cg-RX-API-DMAC7.html)
NO (1) NO322446B1 (cg-RX-API-DMAC7.html)
PL (1) PL190900B1 (cg-RX-API-DMAC7.html)
PT (1) PT981347E (cg-RX-API-DMAC7.html)
WO (1) WO1998038996A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA981779B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260313A1 (de) * 2002-12-20 2004-07-15 Siemens Ag Elektrische Maschine mit Wicklungen aus Litze

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
ATE239474T1 (de) * 1997-07-22 2003-05-15 Darwin Discovery Ltd Verwendung von levobupivacain
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
ES2397574T3 (es) 2002-07-30 2013-03-08 Omeros Corporation Procedimiento y soluciones de irrigación oftalmológica
US20050176823A1 (en) * 2004-02-10 2005-08-11 Diaz Robert L. Intra-operative procedure for post-operative pain control
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
CN119677554A (zh) 2022-05-05 2025-03-21 普络夫有限责任公司 麻醉神经阻滞和方法
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260313A1 (de) * 2002-12-20 2004-07-15 Siemens Ag Elektrische Maschine mit Wicklungen aus Litze

Also Published As

Publication number Publication date
ZA981779B (en) 1999-03-03
NO994257L (no) 1999-11-02
HK1022651A1 (en) 2000-08-18
ES2199423T3 (es) 2004-02-16
PL335561A1 (en) 2000-05-08
DK0981347T3 (da) 2003-09-15
DE69814851D1 (de) 2003-06-26
HUP0000873A3 (en) 2002-10-28
WO1998038996A1 (en) 1998-09-11
KR20000075896A (ko) 2000-12-26
EP0981347A1 (en) 2000-03-01
AU6630498A (en) 1998-09-22
US5919804A (en) 1999-07-06
HU225151B1 (en) 2006-07-28
PT981347E (pt) 2003-09-30
PL190900B1 (pl) 2006-02-28
NO322446B1 (no) 2006-10-09
ATE240730T1 (de) 2003-06-15
NO994257D0 (no) 1999-09-02
GB9704352D0 (en) 1997-04-23
CN1249684A (zh) 2000-04-05
HUP0000873A2 (hu) 2000-09-28
JP2001513812A (ja) 2001-09-04
IL131084A0 (en) 2001-01-28
BR9808303A (pt) 2000-05-16
EP0981347B1 (en) 2003-05-21
KR100516676B1 (ko) 2005-09-22
CA2279497A1 (en) 1998-09-11
CA2279497C (en) 2009-01-20
AU730390B2 (en) 2001-03-08
CN1089585C (zh) 2002-08-28

Similar Documents

Publication Publication Date Title
DE69814394T2 (de) Verwendung von levobupivacain
DE69429536T2 (de) Analgetisches Mittel und dessen Verwendung
DE69431729T2 (de) Bromocryptin enthaltende mittel mit beschleunigter freisetzung
DE60126265T2 (de) Zusammensetzung bestehend aus Phentolaminmesylat und deren Verwendung
US5919804A (en) Use of levobupivacaine in facial surgery
DE69118859T2 (de) Behandlung von Schlafstörungen unter Verwendung bestimmter Antidepressiva, z.B. Nefazodon
DE69403969T2 (de) Levobupivacain nützlich zur behandlung von chronischen schmerzen
DE69814852T2 (de) Verwendung von levobupivacaine in der pediatrischen chirurgie
EP0413171A1 (de) Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
DE69934305T2 (de) Verwendung von dexmedetomidine zur sedierung auf der intensivstation
DE69232516T2 (de) Behandlung von neurologischen Zuständen durch eine Interleukin-i-inhibierende Verbindung
DE69628743T2 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
EP0871437B1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE69328792T2 (de) Behandlung von migräne
DE69431986T2 (de) Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE2611976C2 (de) Verwendung von L-Pyroglutamyl-L-histidyl-L-prolinamid oder dessen physiologisch verträglichen Salzen zur Behandlung von Zuständen verminderten Bewußtsein
DE60117541T2 (de) Candesartan zur Behandlung von Migräne
DE69904297T2 (de) Neue verwendung von ropivacain zur schmerzbehandlung
White et al. Evidence indicating central atropine-like actions of psychotogenic piperidyl benzilates
DE1806400A1 (de) Pharmazeutisches Produkt,insbesondere injizierbares Lakalanaesthetikum
Wong et al. Pentamorphone for management of postoperative pain
DE2057174A1 (de) Pharmazeutisches Produkt,insbesondere injizierbares Lokalanaesthetikum
HK1022651B (en) The use of levobupivacaine in facial surgery
DE69007777T2 (de) Derivate der p-Guanidinobenzoesäure zur Behandlung der zerebrovaskulären Kontraktion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition